These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2220244)
1. Density distribution, cytomorphologic features and immunologic characteristics of ovarian and endometrial clear cell carcinomas. Harłozińska A; Rabczyński J; Bar JK; Richter R Acta Cytol; 1990; 34(5):657-63. PubMed ID: 2220244 [TBL] [Abstract][Full Text] [Related]
2. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907 [TBL] [Abstract][Full Text] [Related]
3. Comparison of cellular phenotypes in tumor cyst and ascitic fluid from ovarian serous carcinoma. Harlozinska A; Bar JK; Richter R; Cislo M Acta Cytol; 1992; 36(6):869-74. PubMed ID: 1449024 [TBL] [Abstract][Full Text] [Related]
4. Density distribution and antigenic characterization of cell subpopulations isolated from cystic fluids of ovarian serous neoplasms. Harłozińska A; Bar JK; Rabczyński J; Noworolska A; Richter R; Cisło M Anticancer Res; 1989; 9(1):161-6. PubMed ID: 2705745 [TBL] [Abstract][Full Text] [Related]
5. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Sonoda K; Nakashima M; Kaku T; Kamura T; Nakano H; Watanabe T Cancer; 1996 Apr; 77(8):1501-9. PubMed ID: 8608535 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody against human ovarian tumor-associated antigens. Poels LG; Peters D; van Megen Y; Vooijs GP; Verheyen RN; Willemen A; van Niekerk CC; Jap PH; Mungyer G; Kenemans P J Natl Cancer Inst; 1986 May; 76(5):781-91. PubMed ID: 3517452 [TBL] [Abstract][Full Text] [Related]
7. Morphological and immunological heterogeneity of human ovarian neoplasms. Harłozińska A; Rabczyński J; Bar JK; Richter R Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619 [TBL] [Abstract][Full Text] [Related]
8. HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells. Suzuki N; Aoki D; Tamada Y; Susumu N; Orikawa K; Tsukazaki K; Sakayori M; Suzuki A; Fukuchi T; Mukai M; Kojima-Aikawa K; Ishida I; Nozawa S Gynecol Oncol; 2004 Nov; 95(2):290-8. PubMed ID: 15491748 [TBL] [Abstract][Full Text] [Related]
9. Morphological and phenotypic characterization of a new established ovarian carcinoma cell line (OvBH-1). Bar JK; Harlozińska A Anticancer Res; 2000; 20(5A):2975-80. PubMed ID: 11062710 [TBL] [Abstract][Full Text] [Related]
10. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. Young RH Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813 [TBL] [Abstract][Full Text] [Related]
11. Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. Croghan GA; Wingate MB; Gamarra M; Johnson E; Chu TM; Allen H; Valenzuela L; Tsukada Y; Papsidero LD Cancer Res; 1984 May; 44(5):1954-62. PubMed ID: 6370421 [TBL] [Abstract][Full Text] [Related]
12. Effusion cytodiagnosis of carcinosarcoma derived from the female genital tract: immunohistochemical features of MMP-7 and Ki-67 and immunofluorescence double staining analyses of eight cases. Ikeda K; Tate G; Suzuki T; Mitsuya T Gynecol Oncol; 2005 May; 97(2):323-9. PubMed ID: 15863125 [TBL] [Abstract][Full Text] [Related]
13. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145 [TBL] [Abstract][Full Text] [Related]
14. The expression of CEA, CA 19-9 and HMFG antigens in ovarian clear-cell and endometrioid carcinomas. Helle M; Helin H; Ashorn P; Putkinen EL; Krohn K; Wahlström T Pathol Res Pract; 1992 Feb; 188(1-2):74-7. PubMed ID: 1594502 [TBL] [Abstract][Full Text] [Related]
15. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas. Friedman EL; Hayes DF; Kufe DW Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical detection of ovarian carcinoma cells in serous effusions. Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129 [TBL] [Abstract][Full Text] [Related]
17. [Detection of cancer cells in peritoneal fluid or washing by immunocytochemical staining with monoclonal antibodies]. Zhao Y Zhonghua Fu Chan Ke Za Zhi; 1992 May; 27(3):159-61, 189. PubMed ID: 1382925 [TBL] [Abstract][Full Text] [Related]
18. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Szpak CA; Johnston WW; Lottich SC; Kufe D; Thor A; Schlom J Acta Cytol; 1984; 28(4):356-67. PubMed ID: 6205527 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger. Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706 [TBL] [Abstract][Full Text] [Related]
20. A novel technique for the enrichment of primary ovarian cancer cells. Chan JK; Hamilton CA; Anderson EM; Cheung MK; Baker J; Husain A; Teng NN; Kong CS; Negrin RS Am J Obstet Gynecol; 2007 Nov; 197(5):507.e1-5. PubMed ID: 17980191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]